Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

45
Number of overlapping holdings
41.7%
% of BMED's 119 holdings also in XBI
33.8%
% of XBI's 134 holdings also in BMED
Overlap by Weight
Sector Drift (BMED minus XBI)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in BMED |
Weight in XBI |
Overlap | |
---|---|---|---|---|
GILEAD SCIENCES INC | 3.1% | 2.5% | 2.5% | |
SAREPTA THERAPEUTICS INC | 2.1% | 2.1% | 2.1% | |
NEUROCRINE BIOSCIENCES INC | 1.9% | 2.8% | 1.9% | |
NATERA INC | 1.8% | 2.5% | 1.8% | |
EXACT SCIENCES CORP | 1.7% | 2.1% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
BMED Overweight Relative to XBI
INTUITIVE SURGICAL INC | 5.1% | |
BOSTON SCIENTIFIC CORP | 4.8% | |
ARGENX SE ADR | 3.6% | |
ROCHE HOLDING AG-BR | 2.8% | |
LONZA GROUP AG-REG | 2.6% | |
UCB SA | 2.5% | |
ABBOTT LABORATORIES | 2.3% | |
BIO-TECHNE CORPORATION | 2.1% | |
REPLIGEN CORP | 2.0% | |
WATERS CORP | 2.0% |
BMED Underweight Relative to XBI
INCYTE CORP | -2.4% | |
BIOMARIN PHARMACEUTICAL INC | -2.2% | |
MODERNA, INC. | -2.1% | |
VERTEX PHARMACEUTICALS INC | -2.1% | |
REGENERON PHARMACEUTICALS | -2.0% | |
VAXCYTE, INC. | -2.0% | |
MADRIGAL PHARMACEUTICALS, INC. | -1.9% | |
TG THERAPEUTICS INC | -1.8% | |
HALOZYME THERAPEUTICS INC | -1.7% | |
VIKING THERAPEUTICS, INC. | -1.5% |